XML 109 R91.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Investment in equity investees (Details 5)
¥ in Millions, $ in Millions
3 Months Ended 12 Months Ended
Jun. 18, 2021
CNY (¥)
shares
Jun. 30, 2022
CNY (¥)
Dec. 31, 2021
CNY (¥)
Dec. 31, 2023
CNY (¥)
item
Dec. 31, 2023
USD ($)
Dec. 31, 2022
CNY (¥)
Dec. 31, 2021
CNY (¥)
May 31, 2021
CNY (¥)
Equity method investment with the investment cost allocation                
Carrying value of equity investment       ¥ 30,460   ¥ 28,952    
Gain (loss) from changes in fair value of product       2,092   1,921    
Impairment charges       ¥ 3,043 $ 429 1,969 ¥ 574  
ATRenew                
Equity method investments                
Percentage of the issued and outstanding ordinary shares (in percentage)       34.00%        
Total consideration in cash ¥ 321              
Number of board seat held | item       2        
Number of board seats | item       7        
Total consideration for equity investment               ¥ 4,270
Common stock shares subscribed | shares 2,333,333              
Equity method investment with the investment cost allocation                
Carrying value of equity investment       ¥ 677   1,449    
Proportionate share of investee's net tangible assets and intangible assets       1,308   2,080    
Negative basis difference       (631)   (631)    
Negative basis difference has been assigned to amortizable intangible assets       (450)   (450)    
Negative basis difference has been assigned to deferred tax liabilities       (181)   (181)    
Aggregate market values       1,017   ¥ 1,505    
Gain (loss) from changes in fair value of product             ¥ 2,305  
Impairment charges   ¥ 1,191 ¥ 3,909          
ATRenew | Ordinary shares                
Equity method investments                
Total consideration for equity investment       ¥ 41